Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate
- 1 December 1981
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 33 (1) , 649-654
- https://doi.org/10.1007/bf02409503
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Disorders of Mineral Metabolism in MalignancyPublished by Elsevier ,1978
- Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of CancerNew England Journal of Medicine, 1975
- Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human LeukocytesJournal of Clinical Investigation, 1974
- Medical Management of the Hypercalcemia of MalignancyAnnual Review of Medicine, 1974
- The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatitein vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised ratsCalcified Tissue International, 1970
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969
- Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemiaThe American Journal of Medicine, 1964
- Hypercalcemia in Neoplastic DiseaseArchives of Surgery, 1960